Recent Insider Transactions - AN2 Therapeutics (NASDAQ: ANTX)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ANTX AN2 Therapeutics

Chanda Sanjay / officer: Chief Development Officer

02/26/2025

Buy

$1.13

100,500

$114K

100,500

NASDAQ ANTX AN2 Therapeutics

Day Lucy / officer: Chief Financial Officer

02/26/2025

Sell

$1.13

93,000

$105K

93,000

NASDAQ ANTX AN2 Therapeutics

Eizen Joshua M / officer: See Remarks

02/26/2025

Buy

$1.13

117,000

$132K

117,000

NASDAQ ANTX AN2 Therapeutics

Easom Eric / director, officer: Chief Executive Officer

02/26/2025

Buy

$1.13

290,500

$328K

290,500

NASDAQ ANTX AN2 Therapeutics

Prior Stephen David / officer: Chief Strategy Officer

02/26/2025

Buy

$1.13

56,000

$63K

56,000